Stocksigma LogoStocksigma Logo

Gaudium IVF Reports Q2 Results and Updates IPO Object Timelines

Gaudium IVF and Women Health reported consolidated revenue of ₹3,741.11 lakhs for the quarter ended 30th Sep'26, up 17.9% YoY from ₹3,173.04 lakhs, while

Gaudium IVF Reports Q2 Results and Updates IPO Object Timelines

Gaudium IVF and Women Health Ltd · Others (Uncategorized) · 13 Nov 2026, 4:18 am

Gaudium IVF Reports Q2 Results and Updates IPO Object Timelines Gaudium IVF and Women Health reported consolidated revenue of ₹3,741.11 lakhs for the quarter ended 30th Sep'26, up 17.9% YoY from ₹3,173.04 lakhs, while consolidated profit after tax stood at ₹941.31 lakhs compared to ₹937.91 lakhs in the previous year. The board approved substituting six locations for its planned 19 new IVF centres, maintaining the ₹5,000.00 lakhs outlay with a revised completion target by FY29. Additionally, Dr. Ravish Manchanda was appointed as National Head – Operations Expansion & Strategy, effective 12th Nov'26.

Original exchange filing (PDF)

More announcements from Gaudium IVF and Women Health Ltd

All Gaudium IVF and Women Health Ltd announcements